GOVORESTAT

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C17H10F3N3O3S2
Molecular Weight	425.405
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of GOVORESTAT

Structure Search

SMILES

OC(=O)CC1=NN(CC2=NC3=CC(=CC=C3S2)C(F)(F)F)C(=O)C4=CSC=C14

InChI

InChIKey=ORQGHAJIWGGFJK-UHFFFAOYSA-N

InChI=1S/C17H10F3N3O3S2/c18-17(19,20)8-1-2-13-12(3-8)21-14(28-13)5-23-16(26)10-7-27-6-9(10)11(22-23)4-15(24)25/h1-3,6-7H,4-5H2,(H,24,25)

HIDE SMILES / InChI

Molecular Formula	C17H10F3N3O3S2
Molecular Weight	425.405
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 14:39:54 GMT 2023` Edited by `admin` on `Sat Dec 16 14:39:54 GMT 2023`
Record UNII	6JLQ8K35KK
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

GOVORESTAT

Official Name

English

(4-oxo-3-{[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl}-3,4- dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid

Systematic Name

English

AT007

Code

English

2-(4-oxo-3-((5-(trifluoromethyl)benzo[d]thiazol-2-yl)methyl)-3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid

Systematic Name

English

AT-007

Code

English

GOVORESTAT [USAN]

Common Name

English

govorestat [INN]

Common Name

English

Thieno[3,4-d]pyridazine-1-acetic acid, 3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl]methyl]-

Systematic Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

685219

Created by admin on Sat Dec 16 14:39:55 GMT 2023 , Edited by admin on Sat Dec 16 14:39:55 GMT 2023

FDA ORPHAN DRUG

777720

Created by admin on Sat Dec 16 14:39:55 GMT 2023 , Edited by admin on Sat Dec 16 14:39:55 GMT 2023

FDA ORPHAN DRUG

765620

Created by admin on Sat Dec 16 14:39:55 GMT 2023 , Edited by admin on Sat Dec 16 14:39:55 GMT 2023

Code System Code Type Description

USAN

KL-74

Created by admin on Sat Dec 16 14:39:55 GMT 2023 , Edited by admin on Sat Dec 16 14:39:55 GMT 2023

PRIMARY

INN

11608

Created by admin on Sat Dec 16 14:39:55 GMT 2023 , Edited by admin on Sat Dec 16 14:39:55 GMT 2023

PRIMARY

INN

PUBCHEM

132260161

Created by admin on Sat Dec 16 14:39:55 GMT 2023 , Edited by admin on Sat Dec 16 14:39:55 GMT 2023

PRIMARY

CAS

2170729-29-8

Created by admin on Sat Dec 16 14:39:55 GMT 2023 , Edited by admin on Sat Dec 16 14:39:55 GMT 2023

PRIMARY

SMS_ID

300000020992

Created by admin on Sat Dec 16 14:39:55 GMT 2023 , Edited by admin on Sat Dec 16 14:39:55 GMT 2023

PRIMARY

NCI_THESAURUS

C179088

Created by admin on Sat Dec 16 14:39:55 GMT 2023 , Edited by admin on Sat Dec 16 14:39:55 GMT 2023

PRIMARY

FDA UNII

6JLQ8K35KK

Created by admin on Sat Dec 16 14:39:55 GMT 2023 , Edited by admin on Sat Dec 16 14:39:55 GMT 2023

PRIMARY

Related Record Type Details


					73C27N6Z7U

ALDOSE REDUCTASE

TARGET -> INHIBITOR

Comments:

Reduces toxic galactitol levels and prevents disease complications in GALT deficiency. Brain penetrant.

Qualification:

IC50

Amount:

Related Record Type Details


					6JLQ8K35KK

ACTIVE MOIETY

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
BRAIN/PLASMA RATIO	PHARMACOKINETIC